Camber Capital Management as of June 30, 2016
Portfolio Holdings for Camber Capital Management
Camber Capital Management holds 46 positions in its portfolio as reported in the June 2016 quarterly 13F filing
Company (Ticker) |
Portfolio Weight |
Valued At |
Change in Shares |
Share Count |
Share Price |
|---|---|---|---|---|---|
| Spdr S&p 500 Etf (SPY) | 10.1 | $210M | 1.0M | 209.48 | |
| Teva Pharmaceutical Industries (TEVA) | 9.7 | $201M | 4.0M | 50.23 | |
| Gilead Sciences (GILD) | 7.1 | $146M | 1.8M | 83.42 | |
| Mylan Nv | 5.7 | $119M | 2.7M | 43.24 | |
| Endo International | 3.8 | $79M | 5.0M | 15.59 | |
| Cardiovascular Systems | 3.6 | $75M | 4.1M | 18.38 | |
| Medicines Company | 3.2 | $67M | 2.0M | 33.63 | |
| Biogen Idec (BIIB) | 3.2 | $67M | 275k | 241.82 | |
| CIGNA Corporation | 3.1 | $64M | 500k | 127.99 | |
| Genomic Health | 3.1 | $64M | 2.5M | 25.89 | |
| Orthofix International Nv Com Stk | 3.1 | $64M | 1.5M | 42.40 | |
| Brookdale Senior Living (BKD) | 3.0 | $62M | 4.0M | 15.44 | |
| Select Medical Holdings Corporation (SEM) | 2.9 | $61M | 5.6M | 10.87 | |
| Nektar Therapeutics (NKTR) | 2.9 | $61M | 4.3M | 14.23 | |
| Livanova Plc Ord (LIVN) | 2.9 | $60M | 1.2M | 50.23 | |
| Perrigo Company (PRGO) | 2.5 | $52M | 570k | 90.67 | |
| Ldr Hldg | 2.5 | $51M | 1.4M | 36.95 | |
| AmerisourceBergen (COR) | 2.4 | $50M | 625k | 79.32 | |
| NuVasive | 2.2 | $45M | 750k | 59.72 | |
| Universal American | 2.1 | $45M | 5.9M | 7.58 | |
| Wright Medical Group Nv | 2.1 | $43M | 2.5M | 17.37 | |
| Community Health Systems (CYH) | 2.0 | $42M | 3.5M | 12.05 | |
| Alkermes (ALKS) | 2.0 | $41M | 937k | 43.22 | |
| Endologix | 1.8 | $37M | 3.0M | 12.46 | |
| Valeant Pharmaceuticals Int | 1.6 | $33M | 1.7M | 20.14 | |
| Tenet Healthcare Corporation | 1.5 | $31M | 1.1M | 27.64 | |
| Ariad Pharmaceuticals | 1.4 | $30M | 4.0M | 7.39 | |
| BioScrip | 1.2 | $26M | 10M | 2.55 | |
| Invitae (NVTAQ) | 1.0 | $20M | 2.7M | 7.39 | |
| Syneron Medical Ltd ord | 0.9 | $18M | 2.3M | 7.69 | |
| Arena Pharmaceuticals | 0.9 | $18M | 11M | 1.71 | |
| Sequenom | 0.8 | $16M | 17M | 0.91 | |
| AMAG Pharmaceuticals | 0.7 | $14M | 600k | 23.92 | |
| Ptc Therapeutics I (PTCT) | 0.5 | $11M | 1.5M | 7.02 | |
| Protalix BioTherapeutics | 0.4 | $8.5M | 13M | 0.64 | |
| DURECT Corporation | 0.3 | $7.3M | 6.0M | 1.22 | |
| Biolase Technology | 0.3 | $6.2M | 5.3M | 1.17 | |
| Protalix Biotherapeutics Inc note 4.500% 9/1 | 0.3 | $6.1M | 9.0M | 0.68 | |
| Innocoll | 0.3 | $5.8M | 1.1M | 5.51 | |
| GenMark Diagnostics | 0.3 | $5.6M | 649k | 8.70 | |
| OraSure Technologies (OSUR) | 0.2 | $4.2M | 708k | 5.91 | |
| Catabasis Pharmaceuticals | 0.2 | $3.7M | 1.0M | 3.70 | |
| Targacept Inc Conv Dtd convertible | 0.1 | $1.7M | 1.7M | 1.00 | |
| Dextera Surgical | 0.1 | $1.5M | 838k | 1.80 | |
| Epirus Biopharmaceuticals In | 0.0 | $831k | 1.8M | 0.45 | |
| Biolase Inc warrants | 0.0 | $0 | 1.8M | 0.00 |
